34 related articles for article (PubMed ID: 23328694)
1. Rhodium(III) Dihalido Complexes: The Effect of Ligand Substitution and Halido Coordination on Increasing Cancer Cell Potency.
Lord RM; Zegke M; Basri AM; Pask CM; McGowan PC
Inorg Chem; 2021 Feb; 60(3):2076-2086. PubMed ID: 33463147
[TBL] [Abstract][Full Text] [Related]
2. Ruthenium-nitrosyl complexes with glycine, L-alanine, L-valine, L-proline, D-proline, L-serine, L-threonine, and L-tyrosine: synthesis, X-ray diffraction structures, spectroscopic and electrochemical properties, and antiproliferative activity.
Rathgeb A; Böhm A; Novak MS; Gavriluta A; Dömötör O; Tommasino JB; Enyedy EA; Shova S; Meier S; Jakupec MA; Luneau D; Arion VB
Inorg Chem; 2014 Mar; 53(5):2718-29. PubMed ID: 24555845
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structures of ruthenium di- and tricarbonyl complexes derived from 4,5-diazafluoren-9-one.
Jimenez J; Chakraborty I; Mascharak P
Acta Crystallogr C Struct Chem; 2015 Nov; 71(Pt 11):965-8. PubMed ID: 26524168
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of heteroscorpionate ligands as scaffolds for the generation of Ruthenium(II) metallodrugs in breast cancer therapy.
Domínguez-Jurado E; Ripoll C; Lara-Sánchez A; Ocaña A; Vitórica-Yrezábal IJ; Bravo I; Alonso-Moreno C
J Inorg Biochem; 2024 Apr; 253():112486. PubMed ID: 38266323
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Antiproliferative Insights of Lipophilic Ru(II)-Hydroxy Stearic Acid Hybrid Species.
Drius G; Bordoni S; Boga C; Monari M; Fiori J; Esposito E; Zalambani C; Pincigher L; Farruggia G; Calonghi N; Micheletti G
Molecules; 2023 May; 28(10):. PubMed ID: 37241793
[TBL] [Abstract][Full Text] [Related]
6. Photocytotoxic Activity of Ruthenium(II) Complexes with Phenanthroline-Hydrazone Ligands.
Silva-Caldeira PP; Oliveira Junior ACA; Pereira-Maia EC
Molecules; 2021 Apr; 26(7):. PubMed ID: 33917290
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure and biological evaluation of ruthenium(III) complexes of triazolopyrimidines with anticancer properties.
Fandzloch M; Dobrzańska L; Jędrzejewski T; Jezierska J; Wiśniewska J; Łakomska I
J Biol Inorg Chem; 2020 Feb; 25(1):109-124. PubMed ID: 31741123
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity.
Riccardi C; Musumeci D; Trifuoggi M; Irace C; Paduano L; Montesarchio D
Pharmaceuticals (Basel); 2019 Sep; 12(4):. PubMed ID: 31561546
[TBL] [Abstract][Full Text] [Related]
9. New Heteroleptic Ruthenium(II) Complexes with Sulfamethoxypyridazine and Diimines as Potential Antitumor Agents.
de Melo ACC; Santana JMSVP; Nunes KJRC; Rodrigues BL; Castilho N; Gabriel P; Moraes AH; Marques MA; de Oliveira GAP; de Souza ÍP; Terenzi H; Pereira-Maia EC
Molecules; 2019 Jun; 24(11):. PubMed ID: 31181667
[TBL] [Abstract][Full Text] [Related]
10. Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology?
Nardon C; Brustolin L; Fregona D
Future Med Chem; 2016; 8(2):211-26. PubMed ID: 26807601
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of transition-metal steroid derivatives.
Le Bideau F; Dagorne S
Chem Rev; 2013 Oct; 113(10):7793-850. PubMed ID: 23931623
[No Abstract] [Full Text] [Related]
12. Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.
Łakomska I; Fandzloch M; Muzioł T; Lis T; Jezierska J
Dalton Trans; 2013 May; 42(17):6219-26. PubMed ID: 23328694
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular structure and evaluation of new organometallic ruthenium anticancer agents.
Camm KD; El-Sokkary A; Gott AL; Stockley PG; Belyaeva T; McGowan PC
Dalton Trans; 2009 Dec; (48):10914-25. PubMed ID: 20023922
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and anticancer activity of ruthenium-pyrazole complexes.
David S; Perkins RS; Fronczek FR; Kasiri S; Mandal SS; Srivastava RS
J Inorg Biochem; 2012 Jun; 111():33-9. PubMed ID: 22484498
[TBL] [Abstract][Full Text] [Related]
15. Structure-cytotoxicity relationship for different types of mononuclear platinum(II) complexes with 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine.
Łakomska I; Fandzloch M; Muzioł T; Sitkowski J; Wietrzyk J
J Inorg Biochem; 2012 Oct; 115():100-5. PubMed ID: 22926029
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
